RYBREVANT
RYBREVANT
Approved
DIN Number
02526182
Drug Class
Human
Market Date
Apr 26, 2022
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526182
AIG Number0163501001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FX18 AMIVANTAMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AMIVANTAMABActive
Strength: 350 MG / 7 ML
Monograph: AMIVANTAMAB